GBX 0
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Tate & Lyle plc (BD15.L) in the last 3 months. The average price target is GBX 0, with a high forecast of GBX 0 and a low forecast of £100,000. The average price target represents a -100.00% upside from the last price of GBX 112.
The current consensus among 0 investment analysts is to n/a stock in Tate & Lyle plc (BD15.L). This N/A consensus rating has held steady for over two years.
Tate & Lyle PLC, together with its subsidiaries, provides ingredients and solutions to the food, beverage, and other industries in the United States, the United Kingdom, other European countries, and internationally. It operates through two segments, Speciality Food Ingredients and Bulk Ingredients. The company offers texturants, including corn-based starches, clean-label starches, and stabilizer systems; sweeteners, such as high intensity sweeteners and specialty sweeteners; and health and wellness ingredients comprising dietary fibers and oat proteins. In addition, the company is involved in blending, in-house treasury, pension, and reinsurance businesses; citric acid and sucralose production; and research and development and in-house financing businesses, as well as the provision of acidulants and grains. Tate & Lyle PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.
Read More
